Skip to main content
Biofrontera AG logo

Biofrontera AG — Investor Relations & Filings

Ticker · B8F ISIN · DE000A4BGGM7 LEI · 391200D6GFSVFGFQTL13 F Manufacturing
Open in API
Filings indexed 120 across all filing types
Latest filing 2020-04-09 Report Publication Anno…
Country DE Germany
Listing F B8F

About Biofrontera AG

https://www.biofrontera.com/en/

Biofrontera AG is a biopharmaceutical company that specializes in dermatology. The company develops and markets innovative products for the treatment, care, and protection of the skin. Its core expertise is in photodynamic therapy (PDT), a non-invasive treatment for various skin conditions. Biofrontera's products are primarily focused on treating forms of non-melanoma skin cancer, such as actinic keratosis, field cancerization, and basal cell carcinoma. The portfolio includes both dermatological drugs and medical cosmetics.

Recent filings

Filing Released Lang Actions
Hinweis auf Jahresfinanzbericht vom 01.01.2019 bis zum 31.12.2019
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1042 characters) titled 'Hinweis auf Jahresfinanzbericht' (Notice of Annual Financial Report). It explicitly states that the company is announcing the upcoming publication of its 2019 annual report and provides a link to where the report will be available. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, making it a Report Publication Announcement (RPA).
2020-04-09 German
Datum:09.04.2020
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1032 characters) titled 'Hinweis auf Jahresfinanzbericht' (Notice of Annual Financial Report). It explicitly states that the company is announcing the upcoming publication of its 2019 annual report and provides a link to where the report will be available. Per the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2020-04-09 German
Halbjahresfinanzbericht
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halbjahresfinanzbericht zum 30. Juni 2019' (Half-year financial report as of June 30, 2019) for Biofrontera AG. It contains detailed information on the company's structure, business model, strategy, product portfolio (Ameluz, BF-RhodoLED, Belixos, Xepi, Aktipak), and market operations. As it covers a period shorter than a full fiscal year and provides substantive financial and operational analysis, it is classified as an Interim/Quarterly Report. H1 2019
2019-08-27 German
Hinweis auf Halbjahresfinanzbericht vom 01.01.2019 bis zum 30.06.2019
Report Publication Announcement Classification · 100% confidence The document is a short notification (842 characters) announcing the availability of a half-year financial report. It provides a link to the report and specifies the publication date, fitting the 'Report Publication Announcement' (RPA) criteria perfectly as it is an announcement of a report rather than the report itself.
2019-08-26 German
Datum:26.08.2019
Report Publication Announcement Classification · 100% confidence The document is a short notification (827 characters) announcing the availability of a half-year financial report. It provides a link to the website where the report can be accessed and specifies the publication date. According to the 'Menu vs Meal' rule, since this is a short announcement regarding the publication of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2019-08-26 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2018 bis zum 31.12.2018
Annual Report Classification · 100% confidence The document is a comprehensive annual financial report ('Jahresfinanzbericht') for Biofrontera AG for the fiscal year 2018. It includes detailed balance sheets ('Bilanz'), profit and loss statements ('Gewinn- und Verlustrechnung'), notes on asset development, and a management report ('Lage- und Konzernlagebericht'). As it contains full financial statements and analysis for the fiscal year, it is classified as an Annual Report (10-K). FY 2018
2019-06-03 German

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.